Status:
COMPLETED
Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital
Lead Sponsor:
KK Women's and Children's Hospital
Collaborating Sponsors:
Renew Group
Conditions:
Vital Sign
Heart Rate
Eligibility:
All Genders
3-17 years
Phase:
NA
Brief Summary
This proposal describes the evaluation of a CE-marked, FDA cleared vital signs Surveillance Monitoring system in a paediatric outpatient population in KK Women's and Children's Hospital ("KKH"), the m...
Detailed Description
RENEW's Surveillance Monitoring system is made up of two main components: a patient-worn wireless vital signs monitor (Aingeal) that transmits data over Wi-Fi to a central station software platform (...
Eligibility Criteria
Inclusion
- Male or female paediatric patients, aged between 3 and 17 years
- Patients attending outpatient care at KK Women's and Children's Hospital, Singapore
Exclusion
- Patients with active, implantable devices (such as a pacemaker or ICD)
- Patients with any skin condition or injury affecting the electrode placement site
- Patients that are pregnant
- Those patients who, in the opinion of the clinic staff, are not suitable to participate.
Key Trial Info
Start Date :
January 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03754231
Start Date
January 30 2018
End Date
December 1 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KK Women's and Children's Hospital
Singapore, Singapore, 229899